1. Home
  2. CNM vs ALGN Comparison

CNM vs ALGN Comparison

Compare CNM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core & Main Inc.

CNM

Core & Main Inc.

HOLD

Current Price

$50.26

Market Cap

9.0B

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNM
ALGN
Founded
1996
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNM
ALGN
Price
$50.26
$157.47
Analyst Decision
Buy
Buy
Analyst Count
11
13
Target Price
$60.00
$190.50
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
12-09-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
7.24
N/A
EPS
2.25
5.16
Revenue
$7,740,000,000.00
$3,982,622,000.00
Revenue This Year
$4.45
$2.58
Revenue Next Year
$4.43
$3.41
P/E Ratio
$22.35
$30.45
Revenue Growth
11.02
0.56
52 Week Low
$43.18
$122.00
52 Week High
$67.18
$246.19

Technical Indicators

Market Signals
Indicator
CNM
ALGN
Relative Strength Index (RSI) 55.83 73.38
Support Level $44.59 $144.00
Resistance Level $50.10 $152.99
Average True Range (ATR) 1.61 4.97
MACD 0.65 1.74
Stochastic Oscillator 93.62 92.40

Price Performance

Historical Comparison
CNM
ALGN

About CNM Core & Main Inc.

Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: